Immunophotonics
Immunophotonics is a St. Louis clinical-stage biotechnology company developing Interventional Immuno-Oncology treatments for solid tumors. Its lead asset, IP-001, is designed for administration after tumor ablation to stimulate a systemic immune response.
Key facts
| Also Known As | ImmunoPhotonics, Inc. |
|---|---|
| Business Model | Commerce |
| Legal Name | ImmunoPhotonics, Inc. |
| Company Operating Status | Active |
| Full Address | sitem-insel Freiburgstrasse 3 3010 Bern Switzerland |
| Wellfound ID | immunophotonics |
Contact details
Email and phone for Immunophotonics are available to signed-in members of CliffBio.
Sign in to view